Cynosure Group’s Pfizer PFE Stock Holding History

Cynosure Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,492	Closed	-$263K	–	47
2020 Q1	$263K	Sell	8,492 -1,498	-15%	-$51K	0.19%	57
2019 Q4	$371K	Hold	9,990	–	–	0.2%	54
2019 Q3	$341K	Sell	9,990 -3,534	-26%	-$129K	0.19%	56
2019 Q2	$556K	Buy	+13,524	New	+$537K	0.26%	42

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cynosure Group's PFE Position: Q2 2020 in Review

Cynosure Group sold out of Pfizer (PFE) in Q2 2020, closing a stake of 8,492 shares — an estimated $263K sold.

Cynosure Group first reported a position in PFE in Q2 2019 and held it in 4 quarters. The position peaked at $556K in Q2 2019. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

Cynosure Group reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
Cynosure Group sold 8,492 Pfizer shares in Q2 2020, an estimated $263K.
Cynosure Group first reported a position in Pfizer in Q2 2019 and held it in 4 quarters.
Cynosure Group's Pfizer position peaked at $556K in Q2 2019.
2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Cynosure Group's 13F filing for Q2 2020, filed 10 Aug 2020.